MARKSANS PHARMA Quarterly Results
| Consolidated | Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹754 Cr | ₹720 Cr | ₹620 Cr | ₹708 Cr | ₹682 Cr | ₹642 Cr | ₹591 Cr | ₹560 Cr |
| Expenses | ₹594 Cr | ₹576 Cr | ₹520 Cr | ₹583 Cr | ₹551 Cr | ₹495 Cr | ₹462 Cr | ₹450 Cr |
| Operating Income | ₹161 Cr | ₹144 Cr | ₹100 Cr | ₹126 Cr | ₹131 Cr | ₹147 Cr | ₹128 Cr | ₹110 Cr |
| Other Income | ₹20 Cr | ₹22 Cr | ₹6 Cr | ₹17 Cr | ₹36 Cr | ₹0 Cr | ₹15 Cr | ₹17 Cr |
| Interest | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹5 Cr |
| Depreciation | ₹24 Cr | ₹27 Cr | ₹23 Cr | ₹23 Cr | ₹21 Cr | ₹20 Cr | ₹20 Cr | ₹21 Cr |
| Profit Before Tax | ₹151 Cr | ₹133 Cr | ₹77 Cr | ₹116 Cr | ₹143 Cr | ₹125 Cr | ₹120 Cr | ₹100 Cr |
| Profit After Tax | ₹114 Cr | ₹99 Cr | ₹58 Cr | ₹91 Cr | ₹105 Cr | ₹98 Cr | ₹89 Cr | ₹78 Cr |
| EPS | ₹2.50 | ₹2.17 | ₹1.29 | ₹2.00 | ₹2.31 | ₹2.13 | ₹1.96 | ₹1.73 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| MARKSANS PHARMA | 7.8% | -2.9% | -27% |
| SUN PHARMACEUTICAL INDUSTRIES | 4% | -4.9% | -2.3% |
| DIVIS LABORATORIES | 1.1% | -9.3% | 9.1% |
| CIPLA | 1.5% | -9.3% | -7.3% |
| TORRENT PHARMACEUTICALS | -1.3% | -3.7% | 24% |
| DR REDDYS LABORATORIES | 5% | -0.1% | 3.3% |
| MANKIND PHARMA | -0.4% | -10.9% | -16.1% |
| ZYDUS LIFESCIENCES | 1% | -4.2% | -7% |
| LUPIN | 1.9% | -2% | 7.9% |
MARKSANS PHARMA Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 4.72 % |
| Y-o-Y | 10.64 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Dec2025 | ₹754 Cr | 4.72 | |
| Sep2025 | ₹720 Cr | 16.20 | |
| Jun2025 | ₹620 Cr | -12.49 | |
| Mar2025 | ₹708 Cr | 3.90 | |
| Dec2024 | ₹682 Cr | 6.22 | |
| Sep2024 | ₹642 Cr | 8.69 | |
| Jun2024 | ₹591 Cr | 5.47 | |
| Mar2024 | ₹560 Cr | - | |
MARKSANS PHARMA Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 11.25 % |
| Y-o-Y | 23.17 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Dec2025 | ₹161 Cr | 11.25 | |
| Sep2025 | ₹144 Cr | 44.32 | |
| Jun2025 | ₹100 Cr | -20.38 | |
| Mar2025 | ₹126 Cr | -3.64 | |
| Dec2024 | ₹131 Cr | -11.11 | |
| Sep2024 | ₹147 Cr | 14.31 | |
| Jun2024 | ₹128 Cr | 17.14 | |
| Mar2024 | ₹110 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 6.23 % |
| Y-o-Y | 11.34 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Dec2025 | 21.31% | 6.23 | |
| Sep2025 | 20.06% | 24.21 | |
| Jun2025 | 16.15% | -9.01 | |
| Mar2025 | 17.75% | -7.26 | |
| Dec2024 | 19.14% | -16.31 | |
| Sep2024 | 22.87% | 5.15 | |
| Jun2024 | 21.75% | 11.08 | |
| Mar2024 | 19.58% | - | |
MARKSANS PHARMA Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 14.68 % |
| Y-o-Y | 8.21 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Dec2025 | ₹114 Cr | 14.68 | |
| Sep2025 | ₹99 Cr | 70.34 | |
| Jun2025 | ₹58 Cr | -35.85 | |
| Mar2025 | ₹91 Cr | -13.65 | |
| Dec2024 | ₹105 Cr | 7.47 | |
| Sep2024 | ₹98 Cr | 9.76 | |
| Jun2024 | ₹89 Cr | 14.71 | |
| Mar2024 | ₹78 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | 9.52 % |
| Y-o-Y | -2.21 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Dec2025 | 15.07 % | 9.52 | |
| Sep2025 | 13.76 % | 46.54 | |
| Jun2025 | 9.39 % | -26.70 | |
| Mar2025 | 12.81 % | -16.87 | |
| Dec2024 | 15.41 % | 1.18 | |
| Sep2024 | 15.23 % | 0.99 | |
| Jun2024 | 15.08 % | 8.80 | |
| Mar2024 | 13.86 % | - | |
MARKSANS PHARMA Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 15.21 % |
| Y-o-Y | 8.23 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Dec2025 | ₹2.5 | 15.21 | |
| Sep2025 | ₹2.17 | 68.22 | |
| Jun2025 | ₹1.29 | -35.50 | |
| Mar2025 | ₹2 | -13.42 | |
| Dec2024 | ₹2.31 | 8.45 | |
| Sep2024 | ₹2.13 | 8.67 | |
| Jun2024 | ₹1.96 | 13.29 | |
| Mar2024 | ₹1.73 | - | |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD